WHAT IS CAGRILINTIDE Cagrilintide is a synthetic, long-acting amylin analog peptide developed by Novo Nordisk as a potential treatment for obesity and related metabolic conditions
In my clinical experience, patients with tendinopathy lasting 6-24 months often report: Significant pain reduction by week 2-3 Improved load tolerance during physical therapy by week 4-6 Return to prior activity levels (with appropriate rehab) by week 10-14 Ligament Injuries Partial ligament tears (ankle sprains, knee MCL/LCL sprains, wrist sprains) often leave residual instability and chronic pain
Physical Therapy Enhancement Peptides dont replace physical therapybut they do supercharge it
That continues after the peptide itself is gone
Supports cellular energy production, strength output, and lean muscle maintenance for athletes and active individuals
A common extra is the initial consultation fee , which could add 25 to 50 to your first visit